Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer
Clinical trial NCT05978401 · UNKNOWN
Trial details
- NCT number
- NCT05978401
- Sponsor
- Guangzhou Gloria Biosciences Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-10
- Primary completion
- 2025-04-01
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.